AngioDynamics Executive and Leadership Team

August, 2026

Leadership Overview

AngioDynamics has 6 executives leading key functions including strategy, financial oversight, capital management, fiscal reporting, human capital, and legal compliance.

Focused on advancing medical device innovation, AngioDynamics delivers high-quality solutions to improve patient outcomes while maintaining a robust global presence across diverse healthcare markets.

Leadership Roles at AngioDynamics

  • Chief Executive Officer - Yoel Zabar
  • Chief Financial Officer - Robert Palladino
  • Group Chief Financial Officer - Sibabalo Sibabalo
  • Executive Vice President & Chief Financial Officer - Steve Trowbridge
  • Senior Vice President, Chief Human Resources Officer - Bronfen-moore Marna
  • Chief Legal Officer & Corporate Secretary - Larry Weiss
  • Yoel Zabar - Chief Executive Officer

    Yoel Zabar, the Chief Executive Officer at AngioDynamics, directs the overarching corporate strategy and long-term vision for the medical device portfolio. Zabar manages the alignment of research and development initiatives with global market demands to ensure consistent growth in patient care standards. By coordinating with the board and senior leadership, the Chief Executive Officer drives operational excellence across all international divisions. This leadership role involves identifying emerging healthcare trends and integrating advanced technologies into the existing product pipeline. Yoel Zabar maintains a focus on scaling manufacturing capabilities to meet the needs of diverse healthcare systems worldwide. Through rigorous oversight of organizational performance, the Chief Executive Officer secures the competitive position of the company within the medical technology sector. Ultimately, Zabar fosters a culture of innovation that supports the mission of improving clinical outcomes through high-quality, reliable medical solutions.

    Robert Palladino - Chief Financial Officer

    Robert Palladino, the Chief Financial Officer at AngioDynamics, manages the fiscal health and capital allocation strategies necessary for sustained innovation. Palladino oversees the financial planning and analysis functions, ensuring that resource distribution supports the development of high-quality medical devices. By monitoring global market fluctuations, the Chief Financial Officer mitigates financial risks while optimizing the balance sheet for long-term stability. This role requires close collaboration with operational leaders to align budgetary goals with the broader corporate mission of improving patient outcomes. Robert Palladino directs the implementation of financial controls that enhance transparency and accountability across all business units. Through strategic investment in manufacturing infrastructure, the Chief Financial Officer supports the expansion of the product portfolio into new healthcare markets. Ultimately, Palladino ensures the financial foundation remains strong enough to sustain the company's commitment to medical excellence and global growth.

    Sibabalo Sibabalo - Group Chief Financial Officer

    Sibabalo Sibabalo, the Group Chief Financial Officer at AngioDynamics, architects the consolidated financial reporting frameworks that govern the company's worldwide operations. Sibabalo monitors the performance of regional business segments to ensure adherence to corporate fiscal targets and regulatory standards. By analyzing complex data sets, the Group Chief Financial Officer provides actionable insights that guide executive decision-making regarding product distribution and market penetration. This leadership position involves managing the integration of financial systems across international borders to streamline operational efficiency. Sibabalo Sibabalo coordinates with external auditors and internal stakeholders to maintain rigorous compliance with global accounting principles. Through the optimization of cash flow management, the Group Chief Financial Officer supports the company's ability to invest in cutting-edge medical technology. Ultimately, Sibabalo strengthens the financial integrity of the organization, ensuring that resources effectively reach the markets where patient outcomes require the most significant improvement.

    Steve Trowbridge - Executive Vice President & Chief Financial Officer

    Steve Trowbridge, the Executive Vice President & Chief Financial Officer at AngioDynamics, executes the strategic financial planning required to scale the company's medical device manufacturing capabilities. Trowbridge oversees the treasury functions and investor relations, ensuring that capital markets understand the value proposition of the diverse product portfolio. By directing the financial strategy for large-scale projects, the Executive Vice President & Chief Financial Officer facilitates the expansion of distribution networks into key healthcare regions. This role involves balancing short-term profitability with the long-term investment needed for medical innovation. Steve Trowbridge works with the executive team to evaluate potential partnerships that enhance the company's market position. Through disciplined cost management and revenue forecasting, the Executive Vice President & Chief Financial Officer ensures that operational activities remain aligned with the overarching goal of improving patient outcomes. Ultimately, Trowbridge secures the financial resources necessary to maintain a leadership position in the global medical device industry.
    Steve Trowbridge

    Bronfen-moore Marna - Senior Vice President, Chief Human Resources Officer

    Bronfen-moore Marna, the Senior Vice President, Chief Human Resources Officer at AngioDynamics, directs the talent acquisition and organizational development strategies that support the company's mission. Marna oversees the cultivation of a high-performance workforce capable of driving innovation in medical device manufacturing. By implementing comprehensive training programs, the Senior Vice President, Chief Human Resources Officer ensures that employees possess the technical expertise required to maintain global quality standards. This leadership role involves fostering an inclusive corporate culture that attracts top-tier talent across all international operations. Bronfen-moore Marna manages the alignment of human capital initiatives with the strategic objectives of the executive team. Through the development of performance management systems, the Senior Vice President, Chief Human Resources Officer promotes accountability and professional growth within the organization. Ultimately, Marna builds the human infrastructure necessary to sustain the company's commitment to improving patient outcomes through advanced medical solutions.
    Bronfen-moore Marna
    Larry Weiss, the Chief Legal Officer & Corporate Secretary at AngioDynamics, architects the legal framework that protects the company's intellectual property and ensures compliance with global healthcare regulations. Weiss manages the governance processes and board relations, providing the necessary oversight to maintain corporate integrity. By navigating the complex regulatory landscape of medical device manufacturing, the Chief Legal Officer & Corporate Secretary mitigates legal risks associated with international distribution. This role involves drafting and negotiating strategic partnerships that expand the company's reach into new healthcare markets. Larry Weiss coordinates with internal departments to ensure that all product development activities adhere to safety and quality standards. Through the management of corporate records and legal filings, the Chief Legal Officer & Corporate Secretary supports the transparency required for public market operations. Ultimately, Weiss safeguards the company's reputation and assets, allowing the organization to focus on the core mission of improving patient outcomes.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding AngioDynamics Top Executives and Leadership Team

    Who leads AngioDynamics?
    AngioDynamics is led by Yoel Zabar (Chief Executive Officer), along with executives such as Robert Palladino (Chief Financial Officer) and Sibabalo Sibabalo (Group Chief Financial Officer).
    Who is part of AngioDynamics’s executive team?
    The executive team of AngioDynamics includes leaders such as Yoel Zabar (Chief Executive Officer), Robert Palladino (Chief Financial Officer), Sibabalo Sibabalo (Group Chief Financial Officer) and other senior executives.
    How many executives does AngioDynamics have?
    AngioDynamics has 6 executives leading key business areas.
    What roles are included in AngioDynamics’s leadership team?
    The leadership team of AngioDynamics includes roles such as Chief Executive Officer, Chief Financial Officer, Group Chief Financial Officer, Executive Vice President & Chief Financial Officer, Senior Vice President, Chief Human Resources Officer.